Comparison of Gum® HydralTM Moisturizing Gel and Biotene® Oral Gel in Dry Mouth Sensation Reduction
NCT05342272 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2022-04-22
Summary
Background. Xerostomia is estimated to affect up to 50% of the adult population and especially the elderly suffer from dry mouth sensation. Our aim was to compare the efficacy of GUM® Hydral® Moisturizing Gel and Biotene® Oral Balance Gel in dry mouth sensation reduction.
Study design and Methods. Forty patients, reporting dry mouth sensation between 4 to 10 on a 0 (no discomfort) to 10 (extreme discomfort) scale, were divided in two parallel groups respectively treated with GUM® Hydral® and Biotene® Gel following a stratified randomization list (t0). Patients and the research assistants were blinded to group assignment. Patients underwent measurements of unstimulated and stimulated whole saliva flow and weekly (t1, t2, t3, t4) were asked to fill in a patient questionnaire and daily a journal to evaluate the dry mouth symptoms and the subjective perception of changes in the symptoms during one month of treatment. After data collection (t1-t4), patients were medically followed over the next six months in order to detect any long-term side effects (t5).
Conditions
- Xerostomia
Interventions
- DRUG
-
Betaine taurine PVP gel
At the beginning of the trial (t0) each patient received a print-out summarizing the instructions for use of the products: they were instructed to apply during a 28 days treatment period 1 to 2 cm of GUM Hydral® gel to gums, oral mucosa membrane and tongue, repeating as many times as necessary, and to brush their teeth with GUM® Technique® Pro soft compact toothbrush (Sunstar Europe S.A., Etoy, Switzerland) using GUM® Hydral® Toothpaste (Sunstar Europe S.A., Etoy, Switzerland) at least twice a day. The first application was done by the participants themselves under the supervision of the same operator that provided them both oral and written usage instructions. They had to refrain from using any other commercial mouthrinse, toothpaste or saliva supplements during the trial.
- DRUG
-
Xylitol, Lactoperoxidase, Lysozyme, Lactoferrin
At the beginning of the trial (t0) each patient received a print-out summarizing the instructions for use of the products: they were instructed to apply during a 28 days treatment period 1 to 2 cm of Biotene® Oral Balance gel to gums, oral mucosa membrane and tongue, repeating as many times as necessary, and to brush their teeth with GUM® Technique® Pro soft compact toothbrush (Sunstar Europe S.A., Etoy, Switzerland) using GUM® Hydral® Toothpaste (Sunstar Europe S.A., Etoy, Switzerland) at least twice a day. The first application was done by the participants themselves under the supervision of the same operator that provided them both oral and written usage instructions. They had to refrain from using any other commercial mouthrinse, toothpaste or saliva supplements during the trial.
Sponsors & Collaborators
-
Sunstar Suisse
collaborator UNKNOWN -
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
lead OTHER
Principal Investigators
-
Domenico Dalessandri, Prof. · Università degli Studi di Brescia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-22
- Primary Completion
- 2018-01-26
- Completion
- 2018-10-30
Countries
- Italy
Study Locations
More Related Trials
-
Exploratory Study in the Relief of Drug-induced Xerostomia Associated With Hyposialia
NCT02005328 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy of 3M Dry Mouth Moisturizing Spray
NCT04186806 ·Status: COMPLETED ·Phase: NA
-
Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms
NCT02641912 ·Status: COMPLETED ·Phase: NA
-
Improvement of Dry Mouth Sufferers After Using an Experimental Dry Mouth Rinse Compared to a Water Control
NCT04189081 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic Diseases
NCT02317172 ·Status: COMPLETED ·Phase: NA
-
Clinical Study New Gel for Xerostomia
NCT04184908 ·Status: UNKNOWN ·Phase: PHASE1
-
"Hyaluronan" Formulation for Type 2 Diabetic Patients With Dry Mouth
NCT03281486 ·Status: COMPLETED ·Phase: NA
-
CLINICAL EVALUATION OF THE EFFICACY OF AN INTRA ORAL SPRAY FOR PATIENTS WITH XEROSTOMIA
NCT04719091 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Natural Enzymes Mouthwash: a Randomised Controlled Trial
NCT05640362 ·Status: COMPLETED ·Phase: NA
-
Beneficial Effects of Natural Products on Management of Xerostomia
NCT06217614 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Oxygenated Glycerol Triesters to Treat Xerostomia
NCT00332618 ·Status: COMPLETED
-
Clinical Evaluation of MucoPEG™ for Xerostomia
NCT04986501 ·Status: COMPLETED ·Phase: NA
-
Topical Hyaluronic Acid and Recurrent Aphthous Stomatitis.
NCT04265001 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients
NCT06984848 ·Status: RECRUITING ·Phase: NA
-
A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study
NCT02049112 ·Status: COMPLETED ·Phase: PHASE4
-
Hyaluronic Acid in the Treatment of Hyposalivation
NCT07309588 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis Patients With Xerostomia
NCT06476223 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Exploratory Study on Effect of Whitening Agent With Emulsion Gel in Xerostomic Population
NCT04996069 ·Status: COMPLETED ·Phase: NA
-
Influence of Two Paraffin Wax Chewing Gums of Different Consistency on the Stimulated Saliva Flow Rate
NCT04661761 ·Status: COMPLETED ·Phase: NA
-
"Hyaluronan" Formulation for Dry Mouth in Sleep Apnea Patients
NCT03295019 ·Status: UNKNOWN ·Phase: NA
-
Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use
NCT02522936 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Saliva Substitutes on Dental Hard Tissues in Situ
NCT01165970 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
OGT Spray in the Management of Xerostomia in the Elderly
NCT00350350 ·Status: COMPLETED
-
Topical Management of Xerostomia With Dry Mouth Products
NCT03611283 ·Status: COMPLETED ·Phase: NA
-
Finger-prick Autologous Blood (FAB) for Use in Dry Mouth
NCT03530735 ·Status: UNKNOWN ·Phase: NA